ACT Genomics Collaborates with AIA Hong Kong to Promote Precision Cancer Medicine!

2019-07-29

ACT Genomics is excited to collaborate with AIA Hong Kong to bring ACT Genomics’ leading cancer profiling service to AIA Hong Kong customers. The aim is to take medical insurance cover to a new level by assisting customers to utilize their financial resources more efficiently in obtaining optimal medical treatment.